October - 2019
| Previous Next | Showing Journal 10 of 14 |
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trialThe CRASH-3 Trial Collaborators The Lancet, 2019, Online first October This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
October |
Previous Comments
No Comments yet.
Comment
CRASH-2 trial reported tranexamic acid within 3 h of injury reduces death in patients with traumatic extracranial bleeding. Before CRASH-3 a meta-analysis of all RCTs of tranexamic acid in acute TBI reported two small trials of tranexamic acid in traumatic...